| Ms Maria Z Parizhskaya, MD | |
|
600 Gresham Dr, Sentara Norfolk General Hospital Path Dept, Norfolk, VA 23507-1904 | |
| (757) 388-3221 | |
| (757) 388-3799 |
| Full Name | Ms Maria Z Parizhskaya |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 600 Gresham Dr, Norfolk, Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316000904 | NPI | - | NPPES |
| 1316000904 | Medicaid | VA | |
| P00398802 | Other | RR MCR | |
| 139283 | Other | VA | ANTHEM |
| 89067G2 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0213X | Pathology - Pediatric Pathology | 0101234656 (Virginia) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 0101234656 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Ms Maria Z Parizhskaya, MD Po Box 20452, Psmg Credentialing, Columbus, OH 43220-0452 Ph: (614) 442-2406 | Ms Maria Z Parizhskaya, MD 600 Gresham Dr, Sentara Norfolk General Hospital Path Dept, Norfolk, VA 23507-1904 Ph: (757) 388-3221 |
News Archive
Ontario has taken a major step forward in access to treatment for patients in the province with advanced kidney cancer by granting coverage for TORISELTM (temsirolimus), for advanced renal cell carcinoma (RCC) with poor prognostic features.
Neurologix, Inc. announced today several new results from the Company's successful Phase 2 clinical trial for its novel, investigational gene therapy NLX-P101 for the treatment of Parkinson's disease (PD) as part of a comprehensive presentation of study findings to the National Institutes of Health (NIH) Recombinant DNA Advisory Committee.
Children around the world look to Santa Claus as a model of good behavior. But can this sleigh-riding bearer of goodies also be a model good health habits for adults?
Covidien, a leading global provider of healthcare products, today announced that the U.S. Food and Drug Administration (FDA) recently granted approval to the company's Mallinckrodt business for morphine sulfate oral solution, used to relieve moderate to severe acute and chronic pain in opioid-tolerant patients. The solution will be available as a generic in 100 milligrams per 5 mL (20 milligrams per 1 mL).
› Verified 5 days ago
Dr. Michael A. Bergevin, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 601 Childrens Ln, Norfolk, VA 23507 Phone: 757-668-7007 Fax: 757-668-8658 | |
Dr. Philip Martin Stoll, D.O., D.D.S. Pathology Medicare: Not Enrolled in Medicare Practice Location: 830 Southampton Ave, Suite 100, Norfolk, VA 23510 Phone: 757-683-8366 Fax: 757-683-2589 | |
Dr. David Gabriel Marcheschi, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr, Pathology Dept @ Sentara Norfolk Gen Hosp, Norfolk, VA 23507 Phone: 757-388-3221 Fax: 757-388-3799 | |
Dr. Timothy Bernard Walls, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr, Norfolk, VA 23507 Phone: 757-388-3221 | |
Dr. Wendy Rizzo, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 600 Gresham Dr, Norfolk, VA 23507 Phone: 757-388-3221 | |
Barbara H Amaker, MD Pathology Medicare: Medicare Enrolled Practice Location: 600 Gresham Dr, Dept. Pathology, Norfolk, VA 23507 Phone: 757-388-3221 Fax: 757-388-3799 | |
Dr. James David Post, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 600 Gresham Dr, Pathology Dept, Norfolk, VA 23507 Phone: 757-388-3221 Fax: 757-388-3799 |